These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37710226)

  • 41. Glucometer use and glycemic control among Hispanic patients with diabetes in southern Florida.
    Kenya S; Lebron C; Reyes Arrechea E; Li H
    Clin Ther; 2014 Apr; 36(4):485-93. PubMed ID: 24731865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.
    Guerci B; Drouin P; Grangé V; Bougnères P; Fontaine P; Kerlan V; Passa P; Thivolet Ch; Vialettes B; Charbonnel B;
    Diabetes Metab; 2003 Dec; 29(6):587-94. PubMed ID: 14707887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring.
    Kusunoki Y; Katsuno T; Nakae R; Watanabe K; Akagami T; Ochi F; Tokuda M; Murai K; Miuchi M; Miyagawa J; Namba M
    Diabetes Res Clin Pract; 2015 May; 108(2):342-9. PubMed ID: 25779865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of telemedicine assessment on glycemic variability in children with type 1 diabetes mellitus.
    Peña NV; Torres M; Cardona JA; Iniesta R
    Diabetes Technol Ther; 2013 Feb; 15(2):136-42. PubMed ID: 23289433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical efficacy of Professional Continuous Glucose Monitoring in improving glycemic control among children with Type 1 Diabetes Mellitus: An Open-label Randomized Control Trial.
    Raviteja KV; Kumar R; Dayal D; Sachdeva N
    Sci Rep; 2019 Apr; 9(1):6120. PubMed ID: 30992480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Self-monitoring of blood glucose in type 1 diabetes patients with insufficient metabolic control: focused self-monitoring of blood glucose intervention can lower glycated hemoglobin A1C.
    Skeie S; Kristensen GB; Carlsen S; Sandberg S
    J Diabetes Sci Technol; 2009 Jan; 3(1):83-8. PubMed ID: 20046652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of self-monitoring of blood glucose use on glycated hemoglobin and weight in newly diagnosed, insulin-naïve adult patients with type 2 diabetes.
    Virdi NS; Lefebvre P; Parisé H; Duh MS; Pilon D; Laliberté F; Sundaresan D; Garber L; Dirani R
    J Diabetes Sci Technol; 2013 Sep; 7(5):1229-42. PubMed ID: 24124950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of generic exenatide injection in Chinese patients with type 2 diabetes: a multicenter, randomized, controlled, non-inferiority trial.
    Yang J; Xiao W; Guo L; Li Q; Zhong L; Yang J; Yang J; Gao Y; Tian Q; Hong T
    Acta Diabetol; 2020 Aug; 57(8):991-1000. PubMed ID: 32206903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of continuous glucose monitoring compared with self-monitoring of blood glucose in gestational diabetes patients with HbA1c<6%: a randomized controlled trial.
    Lai M; Weng J; Yang J; Gong Y; Fang F; Li N; Kang M; Xu X; Wang Y
    Front Endocrinol (Lausanne); 2023; 14():1174239. PubMed ID: 37152928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences for Percentage Times in Glycemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset.
    Avari P; Uduku C; George D; Herrero P; Reddy M; Oliver N
    Diabetes Technol Ther; 2020 Mar; 22(3):222-227. PubMed ID: 31613142
    [No Abstract]   [Full Text] [Related]  

  • 51. Current status and influential factors associated with adherence to self-monitoring of blood glucose with type 2 diabetes mellitus patients in grassroots communities: a cross-sectional survey based on information-motivation-behavior skills model in China.
    Lin M; Chen T; Fan G
    Front Endocrinol (Lausanne); 2023; 14():1111565. PubMed ID: 37441499
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical use of continuous glucose monitoring system in gestational diabetes mellitus and type 2 diabetes complicated with pregnancy].
    Song Y; Yang H
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):579-83. PubMed ID: 25354857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a Behavioral Mobile Phone App Intervention for the Self-Management of Type 2 Diabetes: Randomized Controlled Trial Protocol.
    Goyal S; Lewis G; Yu C; Rotondi M; Seto E; Cafazzo JA
    JMIR Res Protoc; 2016 Aug; 5(3):e174. PubMed ID: 27542325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.
    Puhr S; Calhoun P; Welsh JB; Walker TC
    Diabetes Technol Ther; 2018 Aug; 20(8):557-560. PubMed ID: 30036082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups.
    Durán A; Martín P; Runkle I; Pérez N; Abad R; Fernández M; Del Valle L; Sanz MF; Calle-Pascual AL
    J Diabetes; 2010 Sep; 2(3):203-11. PubMed ID: 20923485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor-Driven Virtual Diabetes Clinic: Prospective Trial.
    Majithia AR; Kusiak CM; Armento Lee A; Colangelo FR; Romanelli RJ; Robertson S; Miller DP; Erani DM; Layne JE; Dixon RF; Zisser H
    J Med Internet Res; 2020 Aug; 22(8):e21778. PubMed ID: 32856597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary care physicians identify and act upon glycemic abnormalities found in structured, episodic blood glucose monitoring data from non-insulin-treated type 2 diabetes.
    Polonsky WH; Jelsovsky Z; Panzera S; Parkin CG; Wagner RS
    Diabetes Technol Ther; 2009 May; 11(5):283-91. PubMed ID: 19425876
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of emerging digital technologies and methodologies combined with incentives on HbA1c in patients with type 2 diabetes mellitus: study protocol for a parallel, open randomized controlled trial.
    Zhong S; Jiang J; Liu H; Pan Y
    Trials; 2024 Feb; 25(1):100. PubMed ID: 38303057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Challenging evidence and assumptions: is there a role for self-monitoring of blood glucose in people with type 2 diabetes not using insulin?
    Speight J; Browne JL; Furler J
    Curr Med Res Opin; 2013 Mar; 29(3):161-8. PubMed ID: 23259703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.